AI Article Synopsis

Article Abstract

Mucormycosis is an opportunistic fungal infection indicating a high mortality rate. Among six varieties of involved sites, rhino cerebral mucormycosis (RCM) is not the most uncommon. During the COVID-19 pandemic, with the increase, in predisposing conditions incidence rate of mucormycosis progressed. For aggressive treatment, an early diagnosis can be armored to reduce morbidity and mortality. Clinically RCM poses non-specific symptoms and signs delaying diagnosis. This is associated with orbital cellulitis and sinusitis, one-sided headache behind the eye, diplopia, blurring of visions, nasal congestion, rhinorrhea, epistaxis, nasal hypoesthesia, facial pain and numbness, and a history of black nasal discharge. Not commonly the complications of cranial nerve involvement have been reported. In the present case series, three presentations of facial nerve palsy in COVID-19 associated with mucormycosis are added to the literature database.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886373PMC
http://dx.doi.org/10.7759/cureus.33077DOI Listing

Publication Analysis

Top Keywords

facial nerve
8
nerve palsy
8
covid-19 associated
8
associated mucormycosis
8
case series
8
mucormycosis
5
palsy complication
4
complication covid-19
4
mucormycosis case
4
series mucormycosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!